Response to Letter Regarding Article, “Prognostications of Fibrillations”
We thank Dr Sanna et al for their interest in our review. The sentence to which they refer should have indeed read, “Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL AF) followed a small number of patients out to 3 years; the rate of atrial fibrillation was 30% in those with the implanted cardiac monitor and 3% in those who had routine monitoring.” We apologize for the error and appreciate the contributions that the CRYSTAL AF study has given to the understanding of atrial fibrillation after stroke.
Brian Silver, MD
Comprehensive Stroke Center, Department of Neurology, Rhode Island Hospital/Alpert Medical School of Brown University, Providence, RI
Stephan Windecker, MD
Department of Cardiology, Bern University Hospital, Bern, Switzerland
Dr Silver reports receiving compensation for medical expert review; Joint Commission reviews; adjudication for Women’s Health Initiative and SOCRATES trial; and authorship for Epix, Medlink, and Medscape. Dr Windecker reports having received research grants to the institution from Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, Medicines Company and St Jude, and speaker fees from Astra Zeneca, Eli Lilly, Abbott, Biotronik, Boston Scientific, Bayer, and Biosensors.
Stroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. Letters must reference a Stroke published-ahead-of-print article or an article printed within the past 3 weeks. The maximum length is 750 words including no more than 5 references and 3 authors. Please submit letters typed double-spaced. Letters may be shortened or edited.
- © 2015 American Heart Association, Inc.